Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population PROGRESS Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Patients with - Nasal irrigation - Document - PDFSEARCH.IO

First Page	Meta Content
	Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population PROGRESS Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Patients with Add to Reading List Document Date: 2014-09-17 19:20:17 Open Document File Size: 82,75 KB Share Result on Facebook Company Intersect ENT Inc. / / Country United States / / Event FDA Phase / / Facility Science University / / MedicalCondition severe headaches / chronic infections / frontal sinusitis / inflammation / frontal sinus disease / chronic sinusitis / inflammatory condition leading / / MedicalTreatment sinus surgery / surgery / / Organization FDA / Oregon Health and Science University / / Person Lisa Earnhardt / Tim Smith / / Position principal investigator / president and CEO / the principal investigator of the study / / Product mometasone furoate / PROPEL / / ProvinceOrState California / / Technology drug delivery / / SocialTag Otolaryngology General practice Headaches Sinusitis Sinus Paranasal sinuses Mometasone furoate Balloon sinuplasty Nasal irrigation Medicine

Intersect ENT Enrolls First Patient in Clinical Study to Expand Access to PROPEL Treatment to Broader Patient Population PROGRESS Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Patients with Add to Reading List